Several types of molecules are often measured by single-cell multi-omics methods, providing deeper biological knowledge than can be obtained by examining each molecular layer from different cells. With the use of these single-cell multi-omics technologies, it is possible to identify cellular heterogeneity at several molecular levels within a population of cells as well as the coupling or dissociation of this variation between the collected omic layers.

Conference Registration: https://events.marketsandmarkets.com/4th-annual-single-cell-omics-conference/register

The principles of Single Cell have established themselves as invaluable tool for medical research and novel diagnostic techniques. Current developments in single-cell technologies have created new possibilities for indicating the heterogeneity of tumour cells inside them, identifying unusual cell types, determining the degree of mutation, and eventually directing diagnosis and therapy options.

The use of omics technology aids in the thorough analysis of genome biology (genomics), proteins (proteomics), and RNA molecules (transcriptomics), all of which are employed in the discovery and development of new drugs. Thus, it is highly anticipated that these single-cell omics prospects would revolutionize our capacity to comprehend the scope of omics diversity present in our biological systems.

MarketsandMarkets is delighted to present its 4th Annual Single-Cell Omics Conference, which will take place in Boston, USA, on June 22–23, 2023. Diverse talks on a broad perspective of cutting-edge research and advancement in the field of multi-omics research will be incorporated into the conference. Researchers and scientists from prestigious universities and pharmaceutical businesses from all over the world attend the event, which offers a forum for them to present their research papers and reports and exchange knowledge with academic colleagues.

To know more details about the combined packages and offers at the Co-located events write to us at events@marketsandmarkets.com.

https://events.marketsandmarkets.com/4th-annual-single-cell-omics-conference/register

https://events.marketsandmarkets.com/4th-annual-single-cell-omics-conference/register

Please right profile show me. 

In our first Fireside Chat of 2023, Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, joined Natalie Yeadon, Co-founder & CEO of Impetus Digital, and explored the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies.

Repurposing Off-Patent Drugs Through Crowd Funding - Impetus Digital

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explored the concepts of interventional pharmacoeconomics...

In this episode of Healthcare Goes Digital, Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, sat down with Natalie Yeadon, Co-founder & CEO of Impetus Digital. Among other things, he shared how Chiesi is revolutionizing the lives of people living with rare diseases on a global scale. He also discussed key ways for life science companies to engage with patient communities, the importance of pharmaceutical companies maintaining high social and environmental standards, current market access barriers, and more.

Patient Centric Approaches for Rare and Ultra-Rare Diseases - Impetus Digital

Lawrence Bressler, Head of Value & Market Access, Global Rare Diseases at Chiesi, shared how Chiesi is revolutionizing the lives of people...

A version of this article was previously published on PharmaPhorum.

Trust in life science companies has fluctuated since the start of the pandemic. The reputation of COVID-19 vaccine makers understandably soared early on, as clinical trials were started and completed in record time, giving hopes to millions of people in lockdown. Since then, inconsistent messaging around the need for booster shots, as well as side effects–no matter how rare–have tarnished their name. Likewise, trust in the overall health sector is currently 2 percentage points below January 2020 levels, and far below (11 percentage points) May 2021 levels. One survey puts the percentage of persons with trust in the pharmaceutical industry in 2021 at only 50% in the UK and Canada, with the corresponding percentage in the US being even lower, at 47%. India currently has the highest percentage of trust, at 80%. Read the full blog article here: https://www.impetusdigital.com/2022/05/10/trust-and-transparency-in-pharma/

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic - Impetus Digital

One survey puts the percentage of persons with trust in the pharmaceutical industry in 2021 at only 50% in the UK and Canada...

A-Tek Pharma are a UK MHRA licensed pharmaceutical wholesaler. We hold a strong position at our UK base in Bristol, as well as trading across Europe and the International markets, providing our valued customers with our UK partnered manufactured and branded pharmaceutical medicines. 

I’m looking to get into pharmaceutical supply chain business, any kind of advice will be really helpful and if you want to connect with me please feel free to talk to me. Thank you ☺️

Hi there My name is Kelvin Parnell, Recruiter with Omnicell. One of the leading companies in the Pharmacy Automation Industry. Take a look at our website to learn more about the company and job openings. www.omincell.com/careers If you would like to talk directly, I can be reached at 412-310-6683

Actively looking for new position 

QEdge helps in manage…
I) Quality Processes,
II) Documents – controlled and uncontrolled,
III) Maintain employee training records and dossiers


#qms #qualityassurance #qualitymanagementsystem #documentmanagementsoftware #documentcontrol #documentautomation #trainingsolutions #auditmanagement

A compliant configurable endpoint solution for AUDIT READINESS
1 21 CFR Part 11 compliant
2 AI enabled eQMS
3 Enterprise wide implementation

QEdge helps in managing ...
I) Quality Processes,
II) Documents – controlled and uncontrolled,
III) Maintain employee training records and dossiers

#qms #qualityassurance #qualitymanagementsystem #documentmanagementsoftware #documentcontrol #documentautomation #trainingsolutions #auditmanagement

My name is Irfan (Dir Business Development)

In search of Pharma related jobs

Collaborative Drug Discovery is introducing it's latest platform for semantic drug data: BioHarmony. We are currently looking for those with experience in the preclinical, clinical, or post-approval fields to beta test this product. To learn more and apply check out: https://www.collaborativedrug.com/cdd-bioharmony-beta-program/

CDD’s BioHarmony Beta Program Now Open — Apply Today - Collaborative Drug Discovery Inc. (CDD)

CDD is excited to announce the opening of its BioHarmony Beta Program. BioHarmony is a centralized drug data store, providing semantic data on preclinical, clinical, and postapproval developments. Check out the debut of the BioHarmony

I am in southeastern MA/RI area, and open to a new sales position. I am a tenured professional eager to continue learning and growing in the industry! Thank you for including me in this group!

I have total 5.4 years of experience.

My client is an international pharmaceutical group. They have been present in Luxembourg for more than 20 years.As part of their (continuous) growth, they are recruiting a Quality Assurance Officer (M/F) on permanent contract - position based in Luxembourg City.

Watch this registered talk to listen to our CEO, Dr Dietrich Bruchmann and COO, Dr Hans Lindner, exposing their view on NUVISAN integrated services from research to early clinical phase and how its full-fledged research unit in Berlin can better assist you.In this 45-minute presentation, we'll cover:- NUVISAN's wide range of services: from research to early clinical stage (Phase II).- Expansion of NUVISAN's portfolio with new small molecules drug discovery capabilities and capacities acquired from Bayer.- Live Q&A session.For more, please make an appointment with our sales team on www.calendly.com/nuvisan or send an email to bdinfo@nuvisan.com.

UCB and Ferring Pharmaceuticals Inc. today announced they have entered into a co-promotion agreement to commercialize the prefilled syringe formulation of CIMZIA®(certolizumab pegol) in the United States, specifically for the treatment of Crohn's disease (CD). Ferring will take over marketing, sales promotion, and field medical affairs activities. UCB will continue to be responsible for all product-related activities, including revenue recognition. CIMZIA is an injectable biologic treatment option for adults with moderate to severe Crohn's disease with inadequate response to conventional therapy. UCB will continue to promote and to commercialize the lyophilized formulation of CIMZIA for all indications as well as the prefilled syringe formulation for CIMZIA's rheumatology and dermatology indications.



Crohn's disease is an inflammatory bowel disease causing chronic inflammation of the gastrointestinal (GI) tract.2



Read more: https://prn.to/38Dd6vS

UCB and Ferring Pharmaceuticals Announce Co-Promotion of CIMZIA® (certolizumab pegol) for the Treatment of Adults with Moderate to Severe Crohn's Disease

/PRNewswire/ -- UCB and Ferring Pharmaceuticals Inc. today announced they have entered into a co-promotion agreement to commercialize the prefilled syringe...

Do you know how many hours is your qualification team wasting on writing and reviewing protocols and reports? How many equipment and store areas do you qualify per year? Meet Qloud Thermal Solution at www.qloudapp.com and save time and money. Make it right and easy!

Hi there! Hope you are doing well during this stressful time. I'm a user researcher at a catering marketplace company. We want to understand how medical sales handle catering at work. If this isn't a good time, feel free to ignore. If you welcome distractions, and have 7-8 min to fill out the survey, we'd really appreciate it!

If you complete the survey, as a thank you for your time, you'll be entered in a raffle to win a $100 Amazon.com gift card.

If you are a good fit for further research, you can also opt-in to participate in a follow-up research call and receive a $80 Amazon.com gift card upon completion of the research call.

Survey link: https://www.surveymonkey.com/r/HJN2CTF

Process and Workflow of Ordering Food Survey

Web survey powered by SurveyMonkey.com. Create your own online survey now with SurveyMonkey's expert certified FREE templates.

Hello everybody! My name is Jared Grant and I'm a Marketing major at the University of North Texas with a focus in professional sales. My dream is to be a pharmaceutical sales rep with lots of potential for job advancement and growth. I am brand new and know little about the field and asking all of you for help. What can i do to get ahead of the curve?

We've all seen digital health pilots with promising results - but they rarely get beyond initial stages. Find out how you can successfully scale your efforts into an effective digital health ecosystem with industry experts from Ipsen, Teva, Mymee and Phillips-Medisize at eyeforpharma's FREE webinar!
Sign up now to gain key insights! https://bit.ly/308kFZz

We've all seen digital health pilots with promising results - but they rarely get beyond initial stages. Find out how you can successfully scale your efforts into an effective digital health ecosystem with industry experts from Ipsen, Teva, Mymee and Phillips-Medisize at eyeforpharma's FREE webinar!

Sign up now to gain key insights! https://bit.ly/308kFZz

eBiomarkers.com (domain) is available for sale.